239 related articles for article (PubMed ID: 15486895)
21. Histopathologic analysis of bone marrow and bone metastasis in murine neuroblastoma.
Yoshino K; Tanabe M; Ohnuma N; Takahashi H
Clin Exp Metastasis; 1996 Oct; 14(5):459-65. PubMed ID: 8871540
[TBL] [Abstract][Full Text] [Related]
22. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
DuBois SG; Kalika Y; Lukens JN; Brodeur GM; Seeger RC; Atkinson JB; Haase GM; Black CT; Perez C; Shimada H; Gerbing R; Stram DO; Matthay KK
J Pediatr Hematol Oncol; 1999; 21(3):181-9. PubMed ID: 10363850
[TBL] [Abstract][Full Text] [Related]
23. [The morphological assessment of bone marrow infiltration in neuroblastoma].
Brisigotti M; Medicina D; Bercich L; Bonetti MF; Fabbretti G; Gambini C; Lo Piccolo MS; Milanaccio C; Rosanda C; Garaventa A; De Bernardi B; Callea F
Pediatr Med Chir; 1998; 20(3):169-74. PubMed ID: 9744007
[TBL] [Abstract][Full Text] [Related]
24. Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?
Casey DL; Pitter KL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1204-1209. PubMed ID: 29439882
[TBL] [Abstract][Full Text] [Related]
25. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G
Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292
[TBL] [Abstract][Full Text] [Related]
26. Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer.
Akashi T; Koizumi K; Tsuneyama K; Saiki I; Takano Y; Fuse H
Cancer Sci; 2008 Mar; 99(3):539-42. PubMed ID: 18201276
[TBL] [Abstract][Full Text] [Related]
27. Lymph node sampling in localized neuroblastoma: a Pediatric Oncology Group study.
Contador MP; Johnston S; Smith EI; Shuster JJ; Hayes FA; Castleberry RP
J Pediatr Surg; 1999 Jun; 34(6):967-74. PubMed ID: 10392915
[TBL] [Abstract][Full Text] [Related]
28. Improving Detection of Metastatic Neuroblastoma in Bone Marrow Core Biopsies: A Proposed Immunohistochemical Approach.
Parsons LN; Gheorghe G; Yan K; Simpson P; Jarzembowski JA
Pediatr Dev Pathol; 2016; 19(3):230-6. PubMed ID: 26491958
[TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels.
Granchi D; Corrias MV; Garaventa A; Baglìo SR; Cangemi G; Carlini B; Paolucci P; Giunti A; Baldini N
Bone; 2011 Jan; 48(1):152-9. PubMed ID: 20603237
[TBL] [Abstract][Full Text] [Related]
30. Inconspicuous Presentation of Metastatic Neuroblastoma.
Hatten J; McGuffin A; Mogul M
W V Med J; 2016; 112(4):38-41. PubMed ID: 27491101
[TBL] [Abstract][Full Text] [Related]
31. Urinary dopamine/noradrenaline and dopamine/vanillylmandelic acid ratios as a reflection of different biology of adrenergic clones in children's neuroblastic tumors.
Izbicki T; Bozek J; Perek D; Wozniak W
J Pediatr Surg; 1991 Oct; 26(10):1230-4. PubMed ID: 1779334
[TBL] [Abstract][Full Text] [Related]
32. OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
Tweddle DA; Pinkerton CR; Lewis IJ; Ellershaw C; Cole M; Pearson AD
Med Pediatr Oncol; 2001 Jan; 36(1):239-42. PubMed ID: 11464894
[TBL] [Abstract][Full Text] [Related]
33. Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma.
Granchi D; Garaventa A; Amato I; Paolucci P; Baldini N
Int J Cancer; 2006 Jul; 119(1):146-51. PubMed ID: 16450378
[TBL] [Abstract][Full Text] [Related]
34. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.
Lin F; Zheng SE; Shen Z; Tang LN; Chen P; Sun YJ; Zhao H; Yao Y
Med Oncol; 2011 Jun; 28(2):649-53. PubMed ID: 20349215
[TBL] [Abstract][Full Text] [Related]
35. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Park JR; Bagatell R; Cohn SL; Pearson AD; Villablanca JG; Berthold F; Burchill S; Boubaker A; McHugh K; Nuchtern JG; London WB; Seibel NL; Lindwasser OW; Maris JM; Brock P; Schleiermacher G; Ladenstein R; Matthay KK; Valteau-Couanet D
J Clin Oncol; 2017 Aug; 35(22):2580-2587. PubMed ID: 28471719
[TBL] [Abstract][Full Text] [Related]
36. [The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications].
Faulkner LB; Tamburini A; Tintori V; Paoli A; Tondo A; Bernini G; Medicina D; Brisigotti M; Corrias MV; Scaruffi P; Rosanda C; Lo Piccolo MS; Viscardi E; Milanaccio C; Garaventa A; De Bernardi B
Pediatr Med Chir; 1998; 20(3):175-8. PubMed ID: 9744008
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
[TBL] [Abstract][Full Text] [Related]
38. Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrow.
Bomken SN; Redfern K; Wood KM; Reid MM; Tweddle DA
J Clin Pathol; 2006 Sep; 59(9):927-9. PubMed ID: 16565222
[TBL] [Abstract][Full Text] [Related]
39. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.
Xiang ZL; Zeng ZC; Tang ZY; Fan J; Zhuang PY; Liang Y; Tan YS; He J
BMC Cancer; 2009 Jun; 9():176. PubMed ID: 19508713
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α.
Zhi Y; Lu H; Duan Y; Sun W; Guan G; Dong Q; Yang C
Int J Mol Med; 2015 Feb; 35(2):349-57. PubMed ID: 25503960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
